Aspira Women's Health INC 10-K annual reports
Annual reports — audited financials, the full risk-factor list, and management’s account of the year.
Aspira Womens Health Inc. reported a net loss of $12.78 million for 2025, with substantial doubt about its ability to continue as a going concern, despite a strategic shift aimed at profitability.
10-K: Aspira Women's Health Amends Warrants, Pursues Strategic Alternatives Amidst Financial Uncertainty
Aspira Women's Health is amending warrants and seeking additional capital to address financial challenges and continue operations.
Aspira Women's Health's 10-K filing outlines the company's share structure, voting rights, dividend policies, and compliance with regulatory requirements.